Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
about
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisAntiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisRecent trends: Medical management of infectious keratitisOcular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applicationsNanotechnology-based strategies for treatment of ocular disease.Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis.Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patientsNeuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathologyControlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1Clinical evaluation of deep anterior lamellar keratoplasty using glycerol-cryopreserved corneal tissues for refractory herpetic stromal keratitis: An observational study.Cytomegalovirus-related corneal endotheliitis: A review article.Challenges of corneal infections.Antiadenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods.Topical ganciclovir in the treatment of acute herpetic keratitis.Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium.One year of Clinical Ophthalmology.Epidemic keratoconjunctivitis: A review of current concepts in management.
P2860
Q24186663-27F546CD-22EF-4D3F-B7C4-C77DF7E4C41DQ24235637-64CB1AD4-7C66-4CFF-9137-D0964E87081BQ26775838-502843B2-45DA-4D55-A7D1-B9744CB8E6D4Q27021069-A1EDB573-AC6D-400E-A77E-62398FCDA3E9Q27026675-68FA33D6-AFC1-4353-A08F-71951FC16548Q33681543-16BA67BE-F535-416C-B373-0798E1A737F3Q34597872-693890BE-7398-4F7E-8140-FE5E260446F3Q36748051-7E21A7C1-B17C-4792-85A3-B2E440EA8FA1Q36816198-E5089573-1965-4A1B-818C-21054F014F03Q36905820-B5860EC3-3B30-4277-B8D8-D9CAAE649FB9Q37181670-4756C41E-25F0-4090-8C9A-1010AC5FE6C7Q37466085-B796CBD6-010B-4632-BDAB-52175B05126BQ37605818-7AA98DCB-81E7-48C7-8419-7642E1B7BAD2Q38130491-2A74F753-C48B-4EA6-A9EA-5219E90887D3Q39019254-C3612FF6-3A1E-4EE0-B40D-0E5F3C444A51Q39025523-B0D9BAFC-87BF-4C72-AD64-ADDCCAC1AE81Q39840108-C9B23779-F8AB-4324-9725-258CE1FA71DEQ41925642-CEC68A50-9825-4CD4-AFF8-5C113CD31EB8Q42021819-0CC75F1D-2B9C-48AF-BA63-51FD857807A1Q55365389-9CD3B653-6F18-49D5-8AFC-60186E21AD83
P2860
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
@en
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
@nl
type
label
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
@en
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
@nl
prefLabel
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
@en
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
@nl
P2860
P1476
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes
@en
P2093
Joseph Colin
P2860
P304
P407
P577
2007-12-01T00:00:00Z